Abstract
The progression of prostate cancer is a slow and multiple-step process; clinically detectable prostate cancer normally manifest in aged men, although the lesions may have originated much earlier in life. Animal models that mimic the initiation, progression, and metastasis of human prostate cancer are needed to understand the etiology of prostate cancer and to develop new treatments. Recent progress in mouse genetic engineering technology has led to generation of a series of mouse models for prostate cancer research, which have been widely used for testing impacts of a single or combinations of several gene alterations on the onset, progression, and metastasis of prostate tumors, as well as for assessing the effects of environmental, clinical, and preclinical drugs for prostate cancer prevention and treatment. Although it is possible that no single "perfect" model can recapitulate every aspects of this highly heterogeneous disease, it is expected that the models mimicking certain aspects of prostate cancers will continue to provide preclinical guide to treat this prevalent disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Progress in Molecular Biology and Translational Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
